LICENSE AGREEMENT
EXECUTION
VERSION
THIS
LICENSE AGREEMENT (the
“Agreement”), dated
September 16, 2003 (the “Effective Date”), is
by and
between QUINTESSENCE
PHOTONICS CORPORATION, a
Delaware corporation with its principal
place of business at 00000 Xxxxxxx Xxxxxx, Xxxxxx, Xxxxxxxxxx 00000 (“Licensor”) and
FINISAR
CORPORATION, a
Delaware corporation with a
principal
place of business at 0000 Xxxxxxx Xxxx Xxxxx, Xxxxxxxxx, Xxxxxxxxxx 00000
(“Licensee”).
RECITALS:
A.
|
Licensor
is the creator and owner of certain Technology and Intellectual
Property
(as defined
in Section
1 below), and, upon the Restructuring (as defined below), has the
right to
grant a license to use,
modify, copy, market and sell the Technology and Intellectual Property
(each as defined
below).
|
B.
|
Licensor
owes certain financial obligations to Licensee, as set forth in
a Loan and
Security Agreement
dated November 2, 2001, as amended and restated at January 14,
2002, and
the documents and instruments referenced therein and entered into
thereunder (collectively, the
“Loan Agreement”).
|
C.
|
As
collateral security for the repayment of the loans described in
the Loan
Agreement, Licensor also
granted to Licensee a security interest in Licensor’s intellectual
property (the “Secured
IP”),
pursuant
to that certain Intellectual Property Security Agreement between
the
parties dated
January 14,
2002, as amended (the “IP
Security Agreement”),
which Secured IP included, but was not limited
to (i) any and all Copyright (as defined in the IP Security Agreement);
(ii) any and all trade secrets,
and any and all intellectual property rights in computer software
and
computer software products
now or hereafter existing, created, acquired or held; (iii) any
and all
design
rights which may
be available to Licensor now or hereafter existing, created, acquired
or
held; (iv) any and all Patents
(as defined in the IP Security Agreement); (v) any and all Trademarks
(as
defined in the IP
Security
Agreement); (vi) any and all claims for damages by way of past,
present or
future infringement of any of the rights included above, with the
right,
but not the obligation, to xxx
for and
collect such damages for said use or infringement of the intellectual
property rights identified
above;
(vii) all licenses or other rights to use any of the Copyrights,
Patents
or Trademarks, and
all license
fees and royalties arising from such use to the extent permitted
by such
license or
rights; (viii)
all amendments, renewals and extensions of any of the Copyrights,
Trademarks or
Patents; and
(ix) all proceeds and products of the foregoing, including without
limitation all payments under
insurance
or any indemnity or warranty payable in respect of any of the
foregoing.
|
D.
|
In
consideration of the grant of the licenses set forth in this Agreement
and
certain other
releases and
consideration as set forth in the written agreements executed by
the
parties contemporaneously herewith
(the “Closing
Documents”),
Licensee
has agreed to (i) convert the unpaid balance owing under
the Loan Agreement (after application of certain agreed-upon payments)
into shares
of preferred
stock of Licensor, (ii) cancel and terminate Licensor’s remaining
obligations under
the Loan
Agreement and (iii) terminate the security interest in the Secured
IP
under and pursuant to the
terms
of the IP Security Agreement, all as set forth in the Closing Documents
(the “Restructuring”).
|
E.
|
As
further consideration to Licensee for its agreement to accept shares
of
Licensor’s preferred
stock
in partial payment
of
the balance due under the Loan Agreement, Licensor desires to grant
Licensee
a license to the Licensed IP (as defined below) on the terms and
conditions set forth in this
Agreement
|
EXECUTION
VERSION
(a) |
$5.0
million if terminated during the first three years following the
Effective
Date;
|
(b) |
$5.5
million if terminated during the fourth year following the Effective
Date;
or
|
(c) |
$6.0
million if terminated during the fifth year following the Effective
Date.
|
Notwithstanding the foregoing, in the event that Licensor pays a Forbearance Fee to Licensee pursuant to Section 2.6 above, the applicable Termination Fee set forth above shall be reduced by the amount of such Forbearance Fee paid.
If
this
Agreement is not terminated by Licensor by paying the Termination Fee to
Licensee by the last day of
the
fifth year from the Effective Date, then this Agreement shall continue in
perpetuity.
Except
as
set forth in this Section 4.1, Licensor shall not be entitled to terminate
this
Agreement for any reason.
However, in the event of any breach of this Agreement by Licensee, Licensor
shall have the right to seek
damages, injunctive relief and any other remedies (excluding termination of
this
Agreement) from a court
with jurisdiction over such case. Licensee may terminate this Agreement upon
thirty (30) days prior written notice to Licensor.
4.2
Effect
of Termination. In
the
event of termination of this Agreement for any reason,
(a) |
Licensor
shall have no further obligation to disclose any updates or modifications
to
its Technology or Intellectual Property (including any Derivative
Works
created by
Licensor after the date of termination) to
Licensee;
|
(b) |
All
licenses granted to Licensee under this Agreement shall immediately
terminate, except (i) pursuant to Section 4.2(d) below and (ii) the
licenses to market, distribute, sell, offer for sale, import and
export
and the right to Sublicense shall
survive for a period of six (6) months (the “Sell-off
Period”) with
respect to Licensee’s
inventory of products commercially released prior to the termination
of
this Agreement (excluding any products that are still in development),
but
only to the
extent of those Licensed IP incorporated into Licensee’s commercially
released
products prior to the termination of this Agreement; however, upon
the expiration
of such Sell-off Period, Licensee shall have no further right or
license
whatsoever
with respect to any Licensed IP.
|
(c) |
All
Sublicenses granted to End Users with respect to Licensee’s products
commercially
released prior to the termination of this Agreement (excluding any
products
that are still in development), shall survive the termination of
this
Agreement,
but only to the extent of that Licensed IP incorporated into Licensee’s
commercially released products prior to the termination of this Agreement,
and Licensee
may continue to offer customer support to End Users with respect
to such
commercially
released products;
|
EXECUTION
VERSION
(d) |
In
the event that, prior to the termination of this Agreement, Licensee
has
commercially
released one or more fiber optics products that incorporate any Derivative
Works developed by Licensee prior to the termination of this Agreement,
then Licensee may continue to make, have made, use, manufacture,
market,
distribute, sell, offer for sale, import and export such fiber optics
products and
grant Sublicenses in conjunction therewith, provided that Licensee
shall
pay Licensor
a royalty or license fee as determined below and continue to comply
with
all
of the applicable provisions of this Agreement. Licensor and Licensee
shall jointly
determine the amount of the royalty or license fee within 60 days
of the
termination
of this Agreement. If Licensor and Licensee are unable to reach an
agreement on the amount of the royalty or license fee within such
60-day
period, Licensor and Licensee shall engage InteCap or, if InteCap
is
unavailable for any reason,
a reputable accounting firm which has no prior business relationships
with
either party and which has expertise in the fiber optics and laser
technologies field
(the
“Independent
Expert”), to
recommend a reasonable amount as the royalty or license fee, which
recommendation shall be considered by the parties in good faith.
The costs of engaging the Independent Expert shall be shared equally
by
Licensor
and Licensee. The
recommendation of the Independent Expert shall be non-binding and
may be
rejected by either party, provided that such rejection is made
in good faith. In the event that the recommendation of the Independent
Expert
is rejected in good faith by either party, the amount of the royalty
or
license fee shall be finally and exclusively determined by arbitration
held in Los Angeles, California, in accordance with the Commercial
Rules
of the American Arbitration Association.
Judgment upon any award rendered in such arbitration may be entered
by any court having jurisdiction;
|
(e) |
Each
party shall return to the other party all Confidential Information
belonging to the
other party, except that Licensee may retain Confidential Information
relating to
its surviving rights under subsections (b) and (d) above;
and
|
(f) |
Sections
2.2, 2.5, 2.6, 4.2, 5, 6, 7.3, 7.4 and 8 shall survive termination
of this
Agreement,
as well as any other provisions that by their terms or sense are
intended
to survive.
|
5.
WARRANTIES
AND INDEMNIFICATION.
5.1 Warranties.
Licensor
hereby represents, warrants and covenants to Licensee that, except as may
be
disclosed in writing to Licensee and subject to completion of the Restructuring,
on the Effective Date
and
the date of delivery of any Deliverables:
(a)
|
Licensor
owns all of the Licensed IP and has full power and authority to
grant
Licensee
the rights and licenses granted in this
Agreement;
|
(b)
|
to
Licensor’s Knowledge, (i) the Licensed IP (but excluding any Transferred
IP) and
Licensor’s
Derivative Works are free of any adverse claims, judgments or restrictions
(except as set forth herein) and (ii) are not subject to any third
party
royalty
or other material obligations;
|
(c)
|
to
Licensor’s Knowledge, the Licensed IP (but excluding any Transferred IP)
and Licensor’s Derivative Works do not infringe or misappropriate the
valid patent, copyright, trademark, trade secrets or other intellectual
property rights of any third party,
and Licensor has not received any notice or claim to the contrary.
While
Licensor
has not conducted any searches outside of the U.S. with respect
to such
Licensed
IP and Licensor’s Derivative Works, it has no actual knowledge of any
adverse
claim, judgment, restriction or claim of infringement or misappropriation
arising outside the U.S. with respect to such Licensed IP and Licensor’s
Derivative Works;
|
(d)
|
the
Deliverables will be complete and accurate;
and
|
(e)
|
to
Licensor’s Knowledge, no act has been done or omitted to be done by
Licensor which
has had or could have the effect of impairing or dedicating to
the public,
or entitling
any U.S. or foreign governmental authority or any other Person
to cancel,
forfeit, modify or consider abandoned, any Licensed IP or Derivative
Works, or give
any Person any rights with respect
thereto.
|
EXECUTION
VERSION
5.2 Limitation
of Warranties. EXCEPT
AS
EXPRESSLY SET FORTH HEREIN OR IN ANOTHER
CLOSING
DOCUMENT, NEITHER PARTY MAKES ANY REPRESENTATIONS OR WARRANTIES
OF ANY KIND, WHETHER EXPRESS OR IMPLIED, WITH RESPECT TO ITS TECHNOLOGY,
INTELLECTUAL PROPERTY OR ITS DERIVATIVE WORKS THEREOF, INCLUDING
WITHOUT LIMITATION THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR
A
PARTICULAR PURPOSE. EXCEPT IN THE EVENT OF FRAUD OR INTENTIONAL
WRONGDOING AND EXCEPT FOR LICENSEE’S LIABILITY ARISING FROM BREACH
OF
CONFIDENTIALITY UNDER SECTION 6 BELOW, IN NO EVENT SHALL LICENSOR OR LICENSEE
BE
LIABLE AND EACH PARTY COVENANTS NOT TO BRING ANY CLAIM FOR SPECIAL
OR CONSEQUENTIAL DAMAGES OR FOR ANY INDIRECT DAMAGES, INCLUDING WITHOUT
LIMITATION EXEMPLARY DAMAGES, WHETHER OR NOT SUCH DAMAGES WERE FORESEEN
OR UNFORESEEN.
5.3 Indemnification.
(a)
|
Licensor
shall indemnify, defend and hold Licensee and its customers harmless
from
and
against any costs, expenses, liabilities or damages incurred in
connection
with any or alleged breach of Licensor’s warranties set forth in Section
5.1 above.
|
(b)
|
With
respect to any U.S. infringement claim within the scope of Licensor’s
indemnification
obligation under Section 5.3(a) above, Licensee shall (i) promptly
notify
Licensor of such claim, (ii) grant Licensor sole control of the
defense
and all related
settlement negotiations, and (iii) provide Licensor with the assistance,
information
and authority reasonably necessary to perform the above, at Licensor’s
expense.
Licensee may, at its option and expense, be represented by separate
counsel in
any such action. If Licensor fails to assume or perform its
indemnification obligations
in a reasonable manner, Licensee may assume control of its defense
and
Licensor
shall reimburse Licensee for its reasonable costs and expenses
(including
attorneys’
fees) incurred therein, as well as
payment
of any damages awarded or any reasonable
settlement amounts.
|
(c)
|
To
the extent any Licensed IP is used or incorporated in a commercially
released product
of Licensor, if use of such Licensed IP is enjoined or such Licensed
IP is
believed
by Licensor or held by a court or arbitrator to infringe the valid
patent,
copyright,
trademark, trade secrets or other intellectual property rights
of any
third party
arising under the laws of the U.S., Licensor
shall promptly use commercially reasonable,
good faith efforts, at its election, to obtain a license from such
third
party whose
rights have been infringed, to modify such Licensed IP so it is
non-infringing or to provide to Licensee substitute Licensed IP
that is
non-infringing, without adversely affecting
functionality or performance.
|
(d)
|
Licensor
shall have no liability for infringement to the extent such infringement
is based
on any
Derivative Works created by Licensee (unless such Derivative Works
were
created at Licensor’s express direction) or the Transferred IP, where such
infringement
would not have arisen but for the creation of such Derivative Works
or
Licensee’s
applications or perfection of rights under Section 2.5
above.
|
EXECUTION
VERSION
6.
CONFIDENTIALITY.
6.1 Use
and Disclosure. Licensee
agrees to maintain all trade secrets, source code (if any) and other
confidential
information included in the Deliverables and Licensed IP, including, without
limitation, all documentation
and
information marked or labeled by Licensor as “confidential,” (collectively,
“Confidential
Information”) as
confidential. Licensee shall not disclose the Confidential Information to
any
Persons except on a need-to-know basis. Licensee shall use reasonable commercial
efforts to prevent unnecessary
disclosure of any Confidential Information or trade secrets of Licensor through
or as a result of Licensee’s patent and/or copyright applications or perfection
of rights in the Transferred IP under Section 2.5
above, or through or as a
result
of Licensee’s creation, release, publication or distribution of any of its
Derivative Works. Licensee shall treat the Confidential Information with at
least the same level of protection
as it affords its own confidential information of similar sensitivity, but
not
less than a reasonable level
of
protection. Licensee shall inform its employees and contractors to whom it
discloses the Confidential
Information that under this Agreement they are bound by obligations of
confidentiality. Confidentiality
obligations shall survive for five (5) years from the date the Confidential
Information is disclosed
to Licensee.
6.2 Exceptions. The
obligations of confidentiality do not apply to the extent that information
(i)
is now or
later
becomes generally available to the public without fault or breach of Licensee;
(ii) was rightfully in Licensee’s possession
prior to
disclosure by Licensor; (iii) is independently developed by Licensee without
the
use of any Confidential Information of Licensor; or (iv) is obtained by Licensee
from a third party who has
the
right to disclose it to Licensee and who, to the Knowledge of Licensee, owes
no
obligation of confidentiality
to Licensor.
6.3 Injunctive
Relief. Licensee
acknowledges that Licensor’s Confidential Information is highly valuable to
Licensor, that any breach of Licensee’s confidentiality obligations with respect
thereto may severely damage Licensor,
and
that monetary damages may not be a sufficient remedy for such breach, and,
therefore,
that Licensor is entitled to seek, among any other available remedies, immediate
injunctive and other
equitable relief for any such breach.
7.
PURCHASING
AND MARKETING.
7.1 Trademarks. Licensor
grants to Licensee a nonexclusive right and license to use, reproduce and
display
all Trademarks in connection with Licensee’s marketing and distribution of the
Licensed IP in
an ongoing
manner
consistent with Licensor’s then-current trademark usage standards. Licensee may
also develop
and use its own trademarks and service marks in connection with its products
or
services that use or incorporate the Licensed IP, as described in Section 7.2
below.
7.2 Branding;
Copyright and Trademark Use. Licensee
may, in its discretion, private-label any products
within the scope of the Licensed IP and any Derivative Works created by Licensee
as a product of Licensee,
using Licensee’s own brand names, trademarks and service marks. Product
packaging and documentation for products and services that use or incorporate
the Licensed IP shall also be designed and produced
by Licensee, at its sole discretion. However, Licensee shall include, subject
to
Licensor’s approval
as to form, appropriate trademark, copyright and patent notices of Licensor
in
the documentation for
the
Technology.
7.3 Most
Favored Purchaser Status. Licensor
shall offer Licensee “most favored nation” product pricing
on all products offered or sold by Licensor. Specifically, Licensor agrees
to
sell such products to Licensee
at pricing and terms that are equivalent to or better than the pricing and
terms
offered by Licensor to
other
purchasers of its products, unless such other purchaser has purchased a
materially larger quantity of products
from Licensor. If Licensor
provides
any other purchaser of its products with more favorable pricing
or terms under similar or lesser volumes, Licensor shall promptly notify
Licensee and the pricing and
terms
granted to Licensee will be modified to provide such pricing and terms to
Licensee, effective as of
the
date the more favorable pricing or terms was provided to the third party
purchaser. This right will be perpetual,
notwithstanding the termination of this Agreement.
EXECUTION
VERSION
7.4 Proprietary
Rights in Trademarks. Licensee
will not at any time do or cause to be done any act or thing contesting
or in
any way impairing or tending to impair Licensor’s rights in and to the
Trademarks. All use of the Trademarks by Licensee shall inure to the benefit
of
Licensor. Licensee will at no time adopt or
use,
without Licensor’s prior written consent, any name or xxxx, either alone or in
combination with any other
words or symbols, which is similar to or likely to be confused with the
Trademarks, unless Licensor consents
in writing.
8.
MISCELLANEOUS.
8.1 Entire
Agreement. This
Agreement and the related Closing Documents contain the full and entire
agreement
between
the parties with respect to its subject matter, and supersedes and replaces
all
previous agreements
or understandings, written or oral, between Licensor and Licensee. No
modification or amendment
of this Agreement shall be valid unless in writing and signed by both parties
hereto.
8.2 Force
Maieure. Either
party shall be excused from delays in performing or from any failure to
perform
any of its
duties
under this Agreement to the extent such delays or failures result from causes
beyond
the reasonable control of such party; provided, however, that in order to be
excused from any such delay or failure, such party must promptly notify the
other of the delay and its cause and must diligently act to
mitigate such delay to the extent reasonably possible.
8.3 Assignment. The
benefits of this Agreement shall inure to and be binding upon the successors
and
assigns
of both parties.
However, neither party may assign or transfer this Agreement or any of its
rights hereunder,
nor delegate any of its duties and obligations hereunder, without prior written
consent of the other
party, which shall not be unreasonably withheld. Notwithstanding the foregoing,
subject to the limitations
of Section 2.6 above, Licensee may assign this Agreement to a third party as
part of a sale of all or
substantially all of the assets or stock of Licensee to that third party, or
a
sale of the relevant business line, and
provided that such third party agrees to be bound by the terms of this
Agreement.
8.4 Notice. All
notices and requests in connection with this Agreement shall be given in writing
and may
be
given by registered or certified mail, commercial delivery service, facsimile
or
other customary means of written communication,
delivered to the addresses set forth above or to such other address as the
party
to
receive the notice or request shall designate by notice to the other party.
The
effective date of any notice or request given in connection with this Agreement
shall be the date on which it is received by the addressee.
8.5 Choice
of Law and Jurisdiction. This
Agreement shall be governed by and interpreted in accordance
with the laws of the State of California, without regard to its conflict of
laws
rules. Except as set
forth
in Section 4.2(d) above, the parties agree
to
the non-exclusive jurisdiction and venue of California state
and
federal courts with respect to any action between the parties relating to this
Agreement. In any such
legal action, the prevailing party shall be entitled to an award of its
reasonable costs and attorneys’ fees.
8.6 Waiver. Any
waiver by a party of any covenant, condition or obligation of the other party
must be in
writing and signed by the party asserted to have made the waiver, and any such
waiver shall not be construed to be a waiver
of any
subsequent breach. No failure to exercise any right or power under this
Agreement
or to insist on strict compliance by the other party shall constitute a waiver
of the right in the future
to
exercise such right or power or to insist on strict compliance.
EXECUTION
VERSION
8.7 Severability. If
any
term of this Agreement is held invalid or unenforceable by a court or
arbitrator
of competent jurisdiction, such term shall be reduced or otherwise modified
by
such court or arbitrator to the minimum extent necessary to make it valid and
enforceable. If such term cannot be so modified,
it shall be severed and the parties agree to negotiate in good faith a
replacement term that approximates,
to the maximum extent that is legal and valid, the original
intent of the deleted provision.
8.8 Relationship
of Parties. Licensor
and Licensee are acting hereunder as independent contractors and this Agreement
shall not be construed as authority for either party to act for the other party
in any agency
or
other capacity or to make commitments of any kind for the account of, or on
behalf of, the other
party,
except
to
the extent, and for the purposes, expressly provided for and set forth
herein.
8.9 Compliance
with United States Export Controls. Both
parties hereto shall comply with all applicable
United States export control laws and regulations. Neither party shall export
any Technology or
any
Derivative Works of such Technology, or any products or services that use or
incorporate such Technology or Derivative Works, from the United States to
any
other country except as in compliance with
the
United
States export control laws and regulations.
IN
WITNESS WHEREOF,
the
parties hereto have executed this Agreement by their duly authorized
representatives as of the
Effective
Date.
QUINTESSENCE
PHOTONICS CORPORATION:
FINISAR
CORPORATION:
EXECUTION
VERSION
EXHIBIT
A
Description
of Copyrights
1.
|
List
of process equipment and model numbers used for fabrication of
optoelectronic chips;
|
2.
|
Printout
of equipment settings used during chip fabrication, including gases
used,
flow rates, pressures
and temperatures;
|
3.
|
Printouts
of Emcore process recipes for MOCVD growth of epitaxial layers
used to
grow product;
|
4.
|
Engineering
drawings of specialized fixtures such as bar coating
jigs;
|
5.
|
Engineering
drawings for product packages and
components;
|
6.
|
Description
of above processes and fixtures and their role in manufacturing
process.
|
Description
of Patents
Title
|
Application
Number
|
|||
A
Laser Diode with an Internal Mirror
|
10/163,859
|
|||
De-Tuned
Distributed Feedback Laser Diode
|
60/361,792
|
|||
A
Laser Diode With an Amplification Section
That has a V in Index of Refraction
|
10/379,027
|
|||
A
Laser Diode With A Low Absorption Diode
Junction
|
10/378,723
|
|||
A
Laser Diode With An In-Phase Output
|
10/264,593
|
|||
Compact,
High Power Pulsed Laser Source
|
10/417,920
|
|||
High
Performance Vertically Emitting Lasers
|
10/264,534
|
|||
Mid-Infrared
Laser Diode
|
60/449,667
|
|||
Mid-Infrared
Laser Diode
|
60/449,766
|
Description
of Trademarks
Licensor
currently has no registrations or pending applications for any trademarks or
service marks. As
Licensor
currently has no commercially released products, Licensor is not using any
trademarks or service marks
in
connection with any products or services.
“Quintessence
Photonics Corporation” (QPC) has been in use as Licensor’s corporate name since
December
2000.